ライフサイエンスコーパス: painful neuropathy

1 neurons) that underlie the chronic phase of painful neuropathy.

2 get of several disorders, including a common painful neuropathy.

3 to paclitaxel-induced acute pain and chronic painful neuropathy.

4 and peripheral nerve axons, in patients with painful neuropathy.

5 levels can contribute to the development of painful neuropathies.

6 mutations are associated with two inherited painful neuropathies.

7 to innocuous light touching, is a symptom of painful neuropathies.

8 oximately 80% of these patients experiencing painful neuropathies.

9 hes for Parkinson's disease-linked and other painful neuropathies.

10 There were 22 patients with painful neuropathy and 28 without pain, 26 with sensory

11 hannel function associated with an inherited painful neuropathy and suggest that these physiological

12 D in diabetic rodents exhibiting features of painful neuropathy and the translational potential of th

13 Patients develop painful neuropathy and vascular occlusions that progress

14 rial environment and the pathogenesis of the painful neuropathies associated with the macrophage-depe

15 changes during the progression of persistent painful neuropathy caused by paclitaxel (PTX) in male an

16 asis of erythermalgia, an autosomal dominant painful neuropathy characterized by redness of the skin

17 sticity during the progression of persistent painful neuropathy could be interpreted as a biological

18 ate that a variant of NaV1.7 associated with painful neuropathy depolarizes resting membrane potentia

19 The proportion of painless vs painful neuropathy did not differ between the two groups

20 Sixteen subjects presenting with acute painful neuropathy had neurological and retinal examinat

21 on injury (CCI) to peripheral nerve causes a painful neuropathy in association with a process of axon

22 therapy drugs for treating many cancers, and painful neuropathy is a major dose-limiting adverse effe

23 V1.8 mRNA in the pathogenesis of SNE-induced painful neuropathy, NaV1.8 shRNA vector was delivered by

24 This painful neuropathy not only affects the quality of life

25 hort of patients with sodium channel-related painful neuropathy not responding to currently available

26 occurred in < or = 10% of patients; grade 2 painful neuropathy occurred in 7.5%; and grade 3 palmar-

27 Pathological sensations caused by peripheral painful neuropathy occurring in Type 2 diabetes mellitus

28 or sources of disability and often result in painful neuropathies or the impairment of muscle movemen

29 mol/l], and the mean was higher still in the painful neuropathy subgroup [92.2 (37.1) mmol/l] (P < 0.

30 was not significant (P = 0.45), even in the painful neuropathy subgroup.

31 in the injured nerve and the development of painful neuropathy symptoms.

32 at the extreme, viral infections can induce painful neuropathies that can last for decades.

33 al of modulating NK cell function to resolve painful neuropathy through the clearance of partially da

34 In a mouse model of traumatic painful neuropathy, we used cell sorting, nerve tissue c

35 ility and familial episodic pain disorder or painful neuropathy, while mutations evoking larger membr

36 id substrate of this enzyme, leads to severe painful neuropathy with progressive renal, cardiovascula